Lung Cancer Translational and Emerging Therapies

  • Producent: Taylor
  • Oprawa: Twarda
Wysyłka: Niedostępna
Sugerowana cena detaliczna 513,45 PLN
Nasza cena: 480,08 PLN
Oszczędzasz 6%
Dodaj do Schowka
Zaloguj się
Przypomnij hasło
×
×
Darmowa dostawa
Oferujemy szeroki asortyment - ponad 120 tys. produktów
Dysponujemy solidną wiedzą - działamy już 11 lat
Dbamy o wybór najcenniejszych tytułów

Opis: Lung Cancer Translational and Emerging Therapies - K Pandya

Lung cancer is the leading cause of cancer-related deaths in the United States. Filling a gap in the literature, this resource translates recent laboratory findings into practical applications for the prevention and control of lung cancer. Featuring chapters by seasoned researchers in the field, this reference reviews current advances in imaging, drug development, molecular therapeutics, genetics, immunotherapy, and chemotherapy, to stand at the forefront of technologies for patient diagnosis and treatment.Molecular Biology of Lung Cancer as the Basis for Targeted Therapy. Early Clinical Trial Design Issues: Patient Populations, End Points, and Barriers. Antiangiogenic Therapy for Lung Cancer: Small-Molecule Inhibitors. Antiangiogenic Therapy for Lung Cancer: Antibodies and Other Novel Agents. Epidermal Growth Factor Receptor Inhibition in Non-Small Cell Lung Cancer. Epidermal Growth Factor Receptor Targeted Therapy-Markers of Sensitivity and Response. Other Novel Targeted Therapies in Lung Cancer. Lung Cancer Vaccines. Advances in Chemoradiation Treatment of Locoregionally Advanced Non-Small Cell Lung Cancer. Advances in the Treatment of Brain Metastases. Recent Advances in Imaging for Lung Cancer


Szczegóły: Lung Cancer Translational and Emerging Therapies - K Pandya

Tytuł: Lung Cancer Translational and Emerging Therapies
Autor: K Pandya
Producent: Taylor
ISBN: 9780849390210
Rok produkcji: 2007
Ilość stron: 280
Oprawa: Twarda
Waga: 0.54 kg


Recenzje: Lung Cancer Translational and Emerging Therapies - K Pandya

Zaloguj się
Przypomnij hasło
×
×

Lung Cancer Translational and Emerging Therapies

  • Producent: Taylor
  • Oprawa: Twarda

Lung cancer is the leading cause of cancer-related deaths in the United States. Filling a gap in the literature, this resource translates recent laboratory findings into practical applications for the prevention and control of lung cancer. Featuring chapters by seasoned researchers in the field, this reference reviews current advances in imaging, drug development, molecular therapeutics, genetics, immunotherapy, and chemotherapy, to stand at the forefront of technologies for patient diagnosis and treatment.Molecular Biology of Lung Cancer as the Basis for Targeted Therapy. Early Clinical Trial Design Issues: Patient Populations, End Points, and Barriers. Antiangiogenic Therapy for Lung Cancer: Small-Molecule Inhibitors. Antiangiogenic Therapy for Lung Cancer: Antibodies and Other Novel Agents. Epidermal Growth Factor Receptor Inhibition in Non-Small Cell Lung Cancer. Epidermal Growth Factor Receptor Targeted Therapy-Markers of Sensitivity and Response. Other Novel Targeted Therapies in Lung Cancer. Lung Cancer Vaccines. Advances in Chemoradiation Treatment of Locoregionally Advanced Non-Small Cell Lung Cancer. Advances in the Treatment of Brain Metastases. Recent Advances in Imaging for Lung Cancer

Powiadom o dostępności
Podaj swój e-mail a zostaniesz poinformowany jak tylko pozycja będzie dostępna.
×
Cena 513,45 PLN
Nasza cena 480,08 PLN
Oszczędzasz 6%
Wysyłka: Niedostępna
Dodaj do Schowka
Zaloguj się
Przypomnij hasło
×
×

Darmowa dostawa
Zaloguj się
Przypomnij hasło
×
×
Dodane do koszyka
×